Chimeric’s CEO and managing director, Jennifer Chow, said, “We are delighted with USPTO’s decision to grant patent protection for our CORE-NK platform in the United States, the single largest global market for biopharmaceutical products." …
Chimeric secures US patent for its CHM 0201 cell therapy platform technology
April 8, 2024 Australian Biotech
Latest Video
New Stories
-
TGA seeks nominations for statutory advisory committees
May 7, 2024 - - Latest News -
No timeline from the minister on HTA Review report release and response
May 7, 2024 - - Latest News -
The PBAC chair appointment took effect when it did, because it had to
May 7, 2024 - - Latest News -
Pharmacy groups call for extension of the new Commonwealth Prac Payment
May 7, 2024 - - Latest News -
Amgen and Arrotex announce new osteoporosis-focused partnership
May 7, 2024 - - Latest News -
'The truth is more that they are the heroes of every walk of life'
May 6, 2024 - - Latest News -
HTA review's final report now sits with Health Minister Mark Butler
May 6, 2024 - - Latest News